Hualan Biological Engineering Inc. (SHE:002007)

SHE:002007 Revenue

Hualan Biological Engineering had revenue of 804.53M CNY in the quarter ending June 30, 2026, a decrease of -13.55%. This brings the company's total for the last twelve months to 4.36B, down -3.56% year-over-year. In the year 2025, Hualan Biological Engineering had annual revenue of 4.60B with 4.93% growth. That makes Hualan Biological Engineering the 9,716th largest company in the world by revenue and 1,548th in China.

• Revenue (ttm): 4.36B
• Revenue Growth: -3.56%
• P/S Ratio: 5.36
• Revenue / Employee: 1.06M
• Employees: 4,117
• Market Cap: 23.26B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Blood Product 3.39B 73.7%
• Vaccine Product 1.20B 26.0%
• Others 12.88M 0.3%

By Geography

Chart

• China 4.59B 100.0%
• Overseas 2.27M 0.0%

Fiscal year ended Dec 31, 2025 See the full SHE:002007 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.60B	215.82M	4.93%
Dec 31, 2024	4.38B	-962.68M	-18.02%
Dec 31, 2023	5.34B	824.89M	18.26%
Jan 1, 2023	4.52B	80.78M	1.82%
Jan 1, 2022	4.44B	-587.01M	-11.69%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error